Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
TRVI Coverage
News
Trevi Therapeutics (TRVI) Q4 Loss Narrows to $0.06/Share vs $0.10 Estimate, 37% Better Than Expected
Mar 18, 2026
Event
Trevi Therapeutics, Inc (TRVI) Q4 and Year End 2021 Financial Results and Provide a Corporate Update on March 17, 2022
Mar 18, 2022
Event
Trevi Therapeutics, inc (TRVI) Trevi Therapeutics to Report Q3 2021 Financial Results
Nov 8, 2021
Event
Trevi Therapeutics, inc (TRVI) Q2 2021 Earnings Conference Call
Aug 16, 2021